Articles

Several paclitaxel drug-eluting balloons (DEBs) are currently available on the European market, and several others are in development. There are currently no DEBs available in the United States....

Drug-eluting balloons (DEBs) may offer new options in treating peripheral vessels and restenosis. DEBs already offer an alternative treatment tool in Europe, and the first DEB clinical trial in...

In recent years, many medical device companies saw the underserved lower extremity as an opportunity to enter the market for peripheral artery disease (PAD) treatments. For this reason, device...

The focus on balloon angioplasty largely slipped from the interventional limelight a decade ago after the introduction of stents, but today there is some renewed interest with the advent of new...

Safe delivery of the balloon or stent through fragile vasculature during percutaneous transluminal coronary angioplasty (PTCA) procedures is an important criterion for successful patient outcomes...

Positive AAA Results with Endovascular Approach